APA (7th ed.) Citation

Al Ojaimi, Y., Hergesheimer, R., Chami, A. A., Alarcan, H., Augros, J., Dangoumau, A., . . . Blasco, H. (2025). scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy. PLoS ONE, 20(8), 1. https://doi.org/10.1371/journal.pone.0322021

Chicago Style (17th ed.) Citation

Al Ojaimi, Yara, et al. "ScFv Intrabody Targeting Wildtype TDP-43 Presents Protective Effects in a Cellular Model of TDP-43 Proteinopathy." PLoS ONE 20, no. 8 (2025): 1. https://doi.org/10.1371/journal.pone.0322021.

MLA (9th ed.) Citation

Al Ojaimi, Yara, et al. "ScFv Intrabody Targeting Wildtype TDP-43 Presents Protective Effects in a Cellular Model of TDP-43 Proteinopathy." PLoS ONE, vol. 20, no. 8, 2025, p. 1, https://doi.org/10.1371/journal.pone.0322021.